The Role of Circulating Glucose and Triglyceride Concentrations and Their Interactions with Other “Risk Factors” as Determinants of Arterial Disease in Nine Diabetic Population Samples from the WHO Multinational Study
Kelly M West(University of Oklahoma Health Sciences Center), Judy A. Stober(Environmental Protection Agency), V Schliack(Deutsches Diabetes-Zentrum e.V.), M. M. S. Ahuja(All India Institute of Medical Sciences), Peter H. Bennett, B. Grab, Peter Watkins(King's College Hospital), Oscar Mateo de Acosta, Vili Grabauskas, Eishi Miki(Deutsches Diabetes-Zentrum e.V.), A Czyźyk(Medical University of Warsaw), R John Jarrett(Guy's Hospital), H. Keen(Guy's Hospital), A. S. Krolewski(Medical University of Warsaw), Kosaka Kosaka(The University of Tokyo), John Fuller(University of Verona), A Teuscher(Medical University of Vienna)
Cited by 411
Related Papers
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
|The Lancet|2004|3.8k
Vascular Risk Factors and Diabetic Neuropathy
|New England Journal of Medicine|2005|1.3k
Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes
|The Lancet|1998|743